ClinicalTrials.gg
RecruitingNCT06448494UPOG-DIGUUpdated Jun 7, 2024

Evaluation of the New Peri-Operative Geriatric Units in Ile-de-France, in Digestive and Urological Surgery

An observational study in Digestive and Urological Surgery, sponsored by Gérond'if. Recruiting at 1 site in France. Open to participants aged 75 Years and older. Per ClinicalTrials.gov, last updated 2024-06-07.

Sponsored by Gérond'if · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Feb 2025, 1 year 8 months ago, but the record still lists the study as recruiting.
  • Started May 2023; still recruiting 3 years 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Other
Enrollment
1,400
Ages
75 Years and older
Sex
All
01

Study summary

The main objective of this study is to evaluate the effectiveness of experimental management by digestive or urological "new Peri-Operative Geriatric Units", on post-operative follow-up in the 3 months following the procedure.

Medical follow-up in the 10 days following the operation up to discharge, and patient outcomes in the 3 months following the operation, will be documented.

These data will be compared with data from subjects operated on in the reference year.

Read the detailed description

This is a multicenter, non-interventional, prospective retrospective study:

  • Prospective group: inclusion of patients scheduled to undergo one of the 9 procedures targeted by the "new Peri-Operative Geriatric Units" trial (colectomy, cholecystectomy, , transurethral prostatectomy, transurethral or transcutaneous procedure for non-lithiasis conditions, kidney and ureter procedure and major bladder surgery for tumor condition esophageal, gastric and duodenal procedure for malignancy, transurethral bladder resection)
  • Retrospective group: inclusion of patients who were operated in 2019

This study will assess whether "Peri-Operative Geriatric Units" for digestive or urinary surgery is beneficial for :

  • Medical follow-up in the 10 days following the operation and up to discharge (simple follow-up, complications, return to the operating room, etc.),
  • Patient outcomes in the 3 months following surgery (discharge date, geriatric assessment, rehospitalization, other significant medical events, etc.).

These data will be compared with those of patients operated on in the reference year prior to pandemic Covid-19 (2019), who unlike you will not have benefited from "new Peri-Operative Geriatric Units" care.

02

Conditions studied

  • Digestive and Urological Surgery

Keywords

  • Digestive and Urological Surgery
  • Peri-operative geriatric unit
03

In context

Lead sponsor

Gérond'if is the lead sponsor of 35 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
75 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Elderly patients scheduled to undergo one of the 4 procedures targeted by the study (colectomy, or cholecystectomy, or nephrectomy, or transurethral resection of prostate adenoma)

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male or female subject, aged ≥ 75 years,
  • Subject receiving or having received one of the 9 procedures targeted by the study: colectomy, or cholecystectomy, or nephrectomy, or transurethral resection of prostate adenoma, or transurethral prostatectomy, or transurethral or transcutaneous surgery for non-lithiasis conditions, or kidney and ureter surgery and major bladder surgery for tumor disease, or esophageal, stomach and duodenal surgery for , or transurethral resection of bladder,
  • Subject orally agreeing (non-opposition), after having been informed and having been given a reasonable period of reflection, to participate in the study.

Exclusion criteria

Exclusion Criteria:

  • Patient having to undergo, at the time the study is proposed and over the theoretical period of participation, one or more other interventions already scheduled (other than the 9 mentioned in the inclusion criteria), and which, in the investigator's opinion, could have an impact on the study indicators7
  • Subject unable to understand the purpose of the research, to answer questions and to give his/her decision to participate in the study,
  • Subjects under legal protection or unable to express their consent, in accordance with article L1121-8 of the French Public Health Code,
  • Subject already included in another research project involving the human body,
  • Subject not affiliated to or not benefiting from a social security scheme.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Observational model
Cohort
Time perspective
Other
Enrollment
1,400 participants (estimated)
Patient registry
No

Groups and cohorts

  • Prospective group

    Patients who recieved geriatric perioperative car

  • Retrospective group

    Patients who received standard surgical care

06

What researchers measure

Primary outcomes

  1. Assessment of the effectiveness of experimental management by geriatric peri-operative digestive or urological units

    Time frame: 3 months

Secondary outcomes

  1. Assessment of commorbidity risk according Charlson Comorbidity Index (CCI)

    The Charlson Comorbidity Index (CCI) assesses the level of comorbidity by considering the level of severity of 19 predefined comorbid disorders and the number of disorders present among them.

    Time frame: At inclusion

  2. Assessment of the degree of patient dependence according Katz Index of Independence in Activities of Daily Living (ADL)

    Katz Index of Independence in Activities of Daily Living is an unabbreviated scale title. This Index ranks adequacy of performance in the six functions of bathing, dressing, toileting, transferring, continence, and feeding. Patients are scored yes/no for independence in each of the six functions. A score of 6 indicates full function, 4 indicates moderate impairment, and 2 or less indicates severe functional impairment.

    Time frame: 3 months

  3. Assessment of patient's level of dependence through an appreciation of instrumental activities of daily living according Lawton scale

    Time frame: 3 months

  4. Screening for a nutritional disorder according Body Mass Index (BMI) score

    Time frame: 3 months

  5. Assessment of a patient's pre-operative state of health according The American Society of Anaesthesiologists score (ASA)

    To determine if patient is healthy enough to tolerate surgery and anesthesia

    Time frame: 3 months

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started May 2023 (actual). Primary completion is estimated for Feb 2025, 20 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 4, 2024
First posted
Jun 7, 2024
StartActual
May 31, 2023
Primary completionEst.
Feb 28, 2025
CompletionEst.
Aug 28, 2025
Last update
Jun 7, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 7, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06448494
Lead sponsor
Gérond'if
Responsible party
Sponsor
First posted
Jun 7, 2024
Start date
May 31, 2023
Primary completion
Feb 28, 2025 (estimated)
Completion
Aug 28, 2025 (estimated)
Last update
Jun 7, 2024

Study contacts

Isabelle Dufour
Contact
isabelle.dufour@gerondif.org
+ 33 (0) 185781010
Albatoul Zakaria, PhD
Contact
albatoul.zakaria@gerondif.org
+ 33 (0) 185781010
Olivier Hanon, PhD, MPH
study chair · Geriatric Departement, Broca Hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion